NCT06788509 2025-10-10
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
Janssen Research & Development, LLC
Moonshot Antibodies
Calibr, a division of Scripps Research